Literature DB >> 21565969

Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Jeffrey J Swigris1, Amy L Olson2, Tristan J Huie2, Evans R Fernandez-Perez2, Joshua J Solomon2, David Sprunger2, Kevin K Brown2.   

Abstract

BACKGROUND: A recently published report from the United Kingdom suggested an association between sarcoidosis and pulmonary embolism (PE). We sought to examine whether this association was present among US decedents with sarcoidosis.
METHODS: We used data from the National Center for Health Statistics to investigate the association between sarcoidosis and PE among US decedents from 1988 to 2007.
RESULTS: From 1988 to 2007, there were 46,450,489 deaths in the United States and 23,679 decedents with sarcoidosis mentioned on their death certificates. Among these, 602 (2.54%) had PE mentioned on their death certificates, compared with only 1.13% of the background population (P < .0001 for comparison). The association between sarcoidosis and PE was significant regardless of gender (OR, 2.07; 95% CI, 1.80-2.39; P < .0001 for men and OR, 1.76; 95% CI, 1.59-1.96; P ≤ .0001 for women) or race (OR, 1.57; 95% CI, 1.41-1.76; P < .0001 for blacks and OR, 1.87; 95% CI, 1.63-2.14; P < .0001 for whites). Among decedents with sarcoidosis, there was no difference in risk of PE between men and women (2.30% vs 2.54%, χ(2) = 1.32, P = .25) or between blacks and whites (2.60% vs 2.23%, χ(2) = 3.09, P = .08). The association between sarcoidosis and PE held regardless of age.
CONCLUSIONS: Using death certificate data from 1988 to 2007, we detected an association between sarcoidosis and PE regardless of gender, race, or age. Further investigation is needed to decipher the mechanisms of this apparent association.

Entities:  

Mesh:

Year:  2011        PMID: 21565969      PMCID: PMC3205849          DOI: 10.1378/chest.11-0324

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

Review 1.  Natural history of pulmonary embolism.

Authors:  J E Dalen; J S Alpert
Journal:  Prog Cardiovasc Dis       Date:  1975 Jan-Feb       Impact factor: 8.194

2.  Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study.

Authors:  A P Crawshaw; C J Wotton; D G R Yeates; M J Goldacre; L-P Ho
Journal:  Thorax       Date:  2010-09-13       Impact factor: 9.139

3.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

Authors:  E Neville; A N Walker; D G James
Journal:  Q J Med       Date:  1983

4.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

5.  Sarcoidosis: a long-term follow up study.

Authors:  A G Chappell; W Y Cheung; H A Hutchings
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-06       Impact factor: 0.670

6.  Circulating D dimer in patients with sarcoidosis.

Authors:  A F Shorr; O W Hnatiuk
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

7.  Sarcoidosis: epidemiology and prognosis. A 15-year European study.

Authors:  G Hillerdal; E Nöu; K Osterman; B Schmekel
Journal:  Am Rev Respir Dis       Date:  1984-07

8.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.

Authors:  H A Chapman; C L Allen; O L Stone
Journal:  Am Rev Respir Dis       Date:  1986-03
View more
  23 in total

1.  Bedside ultrasonography for evaluation of pneumothorax.

Authors:  Saadah Alrajab; Abdulsattar Alrajab; Usama Assaad
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

Review 2.  Imaging of Sarcoidosis.

Authors:  Mario Silva; Hilario Nunes; Dominique Valeyre; Nicola Sverzellati
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 3.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

4.  Sarcoidosis as a risk factor for venous thromboembolism.

Authors:  Anna Goljan Geremek; Witold Tomkowski; Marcin Geremek; Elżbieta Puścińska; Grzegorz Małek; Adam Nowiński; Michal Bednarek; Paweł Śliwiński
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

5.  The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?

Authors:  Rajive Tandon; Robert P Baughman; Janice Stanley; Ali A Khan
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 6.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

7.  Sarcoidosis Masquerading as Atrial Fibrillation: Interesting Case Discussion as Well as Recent Advances in Diagnosis and Management of Cardiac Sarcoidosis.

Authors:  Jefferson Curimbaba; João Pimenta; José Marcos Moreira; UlSilvia Carla Sousa Rodrigues; Ester Nei Aparecida Coletta; Carlos A C Pereira
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 8.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

9.  Mortality among African American women with sarcoidosis: data from the Black Women's Health Study.

Authors:  M H Tukey; J S Berman; D A Boggs; L F White; L Rosenberg; Y C Cozier
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-08-01       Impact factor: 0.670

Review 10.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.